Bortezomib Market To Grow at a Steady CAGR by 2028
Bortezomib market is expected to gain market growth in the forecast period of 2021-2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 3.50% in the above mentioned forecast period. Bortezomib is a drug that is used to treat multiple myeloma (a type of cancer of the bone marrow). Bortezomib is also used to treat mantle cell lymphoma patients (a fast-growing cancer that begins in the cells of the immune system). Bortezomib belongs to the antineoplastic agent class of drugs. It functions by destroying cancer cells. Rise in the prevalence of lymphoma, mantle cell lymphoma and multiple myeloma and growing healthcare expenditure are the major factors influencing the market growth rate. Furthermore, advancement in the medical technology, growing investments for R&D activities and growing awareness are the factors that will expand the bortezomib market. Also, rising geriatric population along with growing incidences of cancer will cushion the mar...